Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials.
J Antimicrob Chemother
; 72(1): 268-272, 2017 01.
Article
in En
| MEDLINE
| ID: mdl-27707990
Search on Google
Database:
MEDLINE
Main subject:
Urinary Tract Infections
/
Klebsiella Infections
/
Cephalosporins
/
Penicillanic Acid
/
Escherichia coli Infections
/
Intraabdominal Infections
/
Beta-Lactamase Inhibitors
/
Anti-Infective Agents, Urinary
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2017
Type:
Article